PACTR201705002278236招募中未知
Sildenafil citrate for the treatment of asymmetrical intrauterine growth restriction: A randomized controlled trial
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 Year(s) 至 40 Year(s)（—）
- 性别
- Female
入选标准
- •1.Pregnant Women diagnosed as IUGR.
- •2.Patients aged between 20¿40 years old.
- •3.Consenting to participate.
排除标准
- •1.Severe preeclampsia with a diastolic blood pressure ¿ 110 mmHg on two occasions or systolic blood pressure ¿ 160 mmHg on two occasions and that, together with significant proteinuria (at least 1g/litre).
- •2.Fetus with reversed UA end diastolic flow.
- •3.Fetus diagnosed to have any congenital anomalies.
- •4.Diabetes mellitus with pregnancy.
- •5.Any contraindication for conservative management of IUGR as non-reassuring non-stress test (NST).
- •6.Patients with contraindication for the drugs given as gastric or duodenal ulcer, bleeding tendency and severe hypotension.
- •7.Smokers.
研究者
相似试验
招募中
不适用
managment of oligohydramniosoligohydramniosPACTR201411000920150menoufiya university hospital184
招募中
3 期
The therapeutic effect of Sildenafil Citrate on maternal and fetal outcomes of pregnancies associated with severe preeclampsiaSevere Preeclampsia.Severe pre-eclampsiaIRCT20190201042577N1Mashhad University of Medical Sciences64
已完成
不适用
Sildenafil citrate in erectile dysfunction in diabetesErectile dysfunction in diabetes patientsSLCTR/2007/011Faculty of Medicine, Colombo75
招募中
不适用
Sildenafil Citrate with melatonin and intrauterine growth restrictioIntrauterine growth restriction.Disorders of newborn related to slow fetal growth and fetal malnutritionIRCT20160524028038N6Yasouj University of Medical Sciences88
进行中（未招募）
不适用
Application of Sildenafil in patients with documented coronary vasospasm in order to explore the pathophysiology of coronary vasospasm and the therapeutic effects of Sildenafil in patients suffering from coronary spasmCoronary vasospasm is an abrupt severe vasoconstriction of coronary arteries leading to myocardial ischemia and angina pectoris. The reason for the occurrence of coronary spasm and the cellular mechanism causing coronary spasm is still not elucidated. Thus, an appropriate medical therapy has not been established so far. In patients suffering from coronary vasospasm the possible anti-spastic effect of sildenafil is to be analysed with this study.EUCTR2006-003116-22-DEProf. Sechtem, Department of Cardiology, Robert Bosch Hospital